You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
|
|---|---|
| Published in |
Breast Cancer Research, July 2012
|
| DOI | 10.1186/bcr3231 |
| Pubmed ID | |
| Authors |
Tomasz Byrski, Rebecca Dent, Pawel Blecharz, Malgorzata Foszczynska-Kloda, Jacek Gronwald, Tomasz Huzarski, Cezary Cybulski, Elzbieta Marczyk, Robert Chrzan, Andrea Eisen, Jan Lubinski, Steven A Narod |
Mendeley readers
The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Mexico | 1 | <1% |
| Russia | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 125 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 22 | 17% |
| Researcher | 15 | 11% |
| Student > Master | 15 | 11% |
| Student > Bachelor | 14 | 11% |
| Other | 10 | 8% |
| Other | 18 | 14% |
| Unknown | 37 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 46 | 35% |
| Biochemistry, Genetics and Molecular Biology | 19 | 15% |
| Agricultural and Biological Sciences | 16 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Immunology and Microbiology | 2 | 2% |
| Other | 4 | 3% |
| Unknown | 39 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2016.
All research outputs
#3,415,350
of 25,374,647 outputs
Outputs from Breast Cancer Research
#378
of 2,052 outputs
Outputs of similar age
#22,229
of 177,941 outputs
Outputs of similar age from Breast Cancer Research
#5
of 37 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,941 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.